{"id":60916,"date":"2025-03-12T01:02:37","date_gmt":"2025-03-12T00:02:37","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\/"},"modified":"2025-03-12T01:02:37","modified_gmt":"2025-03-12T00:02:37","slug":"dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\/","title":{"rendered":"Dominic P. Renda Jr. Named Chief Commercial Officer of Wellysis to Lead Global Expansion"},"content":{"rendered":"<div>\n<p>\nVisionary Executive to Drive Growth in Digital Health and Remote Patient Monitoring\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20250311649641\/en\/2407327\/5\/Wellysis_CI_Blue.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250311649641\/en\/2407327\/22\/Wellysis_CI_Blue.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20250311649641\/en\/2407327\/5\/Wellysis_CI_Blue.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250311649641\/en\/2407327\/21\/Wellysis_CI_Blue.jpg\"><\/a><\/p>\n<p>SEOUL, South Korea&#8211;(BUSINESS WIRE)&#8211;Wellysis, a pioneering digital healthcare company spun off from Samsung SDS, announces the appointment of Dominic P. Renda Jr. as Chief Commercial Officer (CCO). In this newly created role, Renda will directly report to CEO and co-founder, Young Juhn and lead global commercial strategy, market expansion, customer success and revenue growth, advancing Wellysis\u2019 mission to transform wellness, care, access and patient outcomes through advanced technology solutions for cardiac health, remote patient monitoring (RPM), hospital-at-home programs, real-time virtual care and research.\n<\/p>\n<p>\nWith over 25 years of executive leadership in healthcare technology, software, and high-growth enterprises, Renda has driven billion-dollar IPOs, scaled global businesses, and forged strategic industry partnerships. His expertise in enterprise technology, SaaS, PaaS, medical wearables, and AI-powered healthcare uniquely positions him to lead Wellysis into its next phase of market leadership.\n<\/p>\n<p>\n\u201cI am honored to join Wellysis at this pivotal moment in digital health,\u201d said Dominic P. Renda Jr. \u201cWellysis\u2019 validated, cutting-edge, remote monitoring, predictive analytics, and Artificial Intelligence are setting new standards in wellness creation, cardiac care, real-time patient management, and global healthcare accessibility. I am excited to expand our impact and bring this life-changing innovation to millions worldwide.\u201d\n<\/p>\n<p>\n<b>A Proven Leader in Healthcare and Technology<\/b>\n<\/p>\n<p>\nRenda\u2019s executive leadership has been instrumental in:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nScaling VivaLNK from a niche provider to a global leader in digital health.\n<\/li>\n<li>\nDriving InterSystems Corporation\u2019s enterprise healthcare platforms, now powering 1 billion+ patient records worldwide.\n<\/li>\n<li>\nLeading NetObjects\u2019 $1.5 billion NASDAQ IPO and guiding Partnerpedia to its high-value acquisition by BMC Software.\n<\/li>\n<li>\nFounding Oceanseed Project, a nonprofit advancing global health, youth empowerment, and sustainability.\n<\/li>\n<\/ul>\n<p>\n<b>About Wellysis: Pioneering the Future of Digital Health<\/b>\n<\/p>\n<p>\nFounded in 2019 as a Samsung SDS spin-off, Wellysis is at the forefront of real-time monitoring, mobile cardiac telemetry, and AI-powered healthcare. Its flagship S-Patch wearable ECG monitor (S-Patch) delivers real-time cardiac insights, empowering clinicians and patients worldwide. With 1,000+ hospitals and clinics globally, Wellysis continues to drive innovation and expand its market footprint.\n<\/p>\n<p>\n\u201cDominic\u2019s leadership and deep expertise in scaling high-growth technology companies will be invaluable as Wellysis expands globally,\u201d said Young Juhn, CEO of Wellysis. \u201cWe are excited to accelerate innovation, forge strategic partnerships, and redefine the future of digital health with his leadership.\u201d\n<\/p>\n<p>\nLearn more at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.wellysis.com&amp;esheet=54222938&amp;newsitemid=20250311649641&amp;lan=en-US&amp;anchor=www.wellysis.com&amp;index=1&amp;md5=322b3112ffa6e2a79861d60bf27175c7\" rel=\"nofollow\" shape=\"rect\">www.wellysis.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nMedia Contact:<br \/>\n<br \/>[Alexa Yu \u2013 <a target=\"_blank\" href=\"mailto:a&#108;&#101;&#120;&#97;&#46;&#121;&#117;&#64;&#119;&#101;&#x6c;&#x6c;&#x79;&#x73;&#x69;&#x73;&#x2e;&#x63;&#x6f;&#x6d;\" rel=\"nofollow\" shape=\"rect\">alexa&#46;yu&#64;wellysis&#46;com<\/a>]<br \/>\n<br \/>Wellysis Public Relations<br \/>\n<br \/><a target=\"_blank\" href=\"ma&#105;&#108;&#116;&#x6f;&#x3a;&#x70;&#x72;es&#115;&#64;&#119;&#x65;&#x6c;&#x6c;&#x79;si&#115;&#46;&#99;&#x6f;&#x6d;\" rel=\"nofollow\" shape=\"rect\">pr&#101;&#115;&#115;&#64;&#x77;&#x65;&#x6c;&#x6c;&#x79;si&#115;&#46;&#99;&#111;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Visionary Executive to Drive Growth in Digital Health and Remote Patient Monitoring SEOUL, South Korea&#8211;(BUSINESS WIRE)&#8211;Wellysis, a pioneering digital healthcare company spun off from Samsung SDS, announces the appointment of Dominic P. Renda Jr. as Chief Commercial Officer (CCO). In this newly created role, Renda will directly report to CEO and co-founder, Young Juhn and &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-60916","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Dominic P. Renda Jr. Named Chief Commercial Officer of Wellysis to Lead Global Expansion - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dominic P. Renda Jr. Named Chief Commercial Officer of Wellysis to Lead Global Expansion - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Visionary Executive to Drive Growth in Digital Health and Remote Patient Monitoring SEOUL, South Korea&#8211;(BUSINESS WIRE)&#8211;Wellysis, a pioneering digital healthcare company spun off from Samsung SDS, announces the appointment of Dominic P. Renda Jr. as Chief Commercial Officer (CCO). In this newly created role, Renda will directly report to CEO and co-founder, Young Juhn and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-12T00:02:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250311649641\/en\/2407327\/22\/Wellysis_CI_Blue.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Dominic P. Renda Jr. Named Chief Commercial Officer of Wellysis to Lead Global Expansion\",\"datePublished\":\"2025-03-12T00:02:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\\\/\"},\"wordCount\":413,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250311649641\\\/en\\\/2407327\\\/22\\\/Wellysis_CI_Blue.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\\\/\",\"name\":\"Dominic P. Renda Jr. Named Chief Commercial Officer of Wellysis to Lead Global Expansion - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250311649641\\\/en\\\/2407327\\\/22\\\/Wellysis_CI_Blue.jpg\",\"datePublished\":\"2025-03-12T00:02:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250311649641\\\/en\\\/2407327\\\/22\\\/Wellysis_CI_Blue.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250311649641\\\/en\\\/2407327\\\/22\\\/Wellysis_CI_Blue.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dominic P. Renda Jr. Named Chief Commercial Officer of Wellysis to Lead Global Expansion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dominic P. Renda Jr. Named Chief Commercial Officer of Wellysis to Lead Global Expansion - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\/","og_locale":"en_US","og_type":"article","og_title":"Dominic P. Renda Jr. Named Chief Commercial Officer of Wellysis to Lead Global Expansion - Pharma Trend","og_description":"Visionary Executive to Drive Growth in Digital Health and Remote Patient Monitoring SEOUL, South Korea&#8211;(BUSINESS WIRE)&#8211;Wellysis, a pioneering digital healthcare company spun off from Samsung SDS, announces the appointment of Dominic P. Renda Jr. as Chief Commercial Officer (CCO). In this newly created role, Renda will directly report to CEO and co-founder, Young Juhn and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\/","og_site_name":"Pharma Trend","article_published_time":"2025-03-12T00:02:37+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250311649641\/en\/2407327\/22\/Wellysis_CI_Blue.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Dominic P. Renda Jr. Named Chief Commercial Officer of Wellysis to Lead Global Expansion","datePublished":"2025-03-12T00:02:37+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\/"},"wordCount":413,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250311649641\/en\/2407327\/22\/Wellysis_CI_Blue.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\/","url":"https:\/\/pharma-trend.com\/en\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\/","name":"Dominic P. Renda Jr. Named Chief Commercial Officer of Wellysis to Lead Global Expansion - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250311649641\/en\/2407327\/22\/Wellysis_CI_Blue.jpg","datePublished":"2025-03-12T00:02:37+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250311649641\/en\/2407327\/22\/Wellysis_CI_Blue.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250311649641\/en\/2407327\/22\/Wellysis_CI_Blue.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/dominic-p-renda-jr-named-chief-commercial-officer-of-wellysis-to-lead-global-expansion\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Dominic P. Renda Jr. Named Chief Commercial Officer of Wellysis to Lead Global Expansion"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60916","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=60916"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60916\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=60916"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=60916"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=60916"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}